East Bay genome sequencing company takes more space in Fremont


The company has raised around $600 million and is pushing toward a commercial release of its genome sequencing system next year.

Previous McCord Development's new hire plans to ramp up next phase of 4,300-acre Generation Park
Next Vacant DTC office building, formerly home to Comcast, hitting auction block